BDX vs PTHS · P/E 34, rev $21.84B vs rev $16.8M
Becton Dickinson and Company (BDX) versus Pelthos Therapeutics Inc. (PTHS) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. PTHS currently screens at market cap $94.7M.
Not investment advice. Open the BDX and PTHS stock pages for the full models.
Not investment advice.